Vistin Pharma ASA (OSTO:VISTINO) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:VISTINO Vistin Pharma ASA OSTO:VISTINO
72 GF Score
Price kr20.50
GF Value kr25.77
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Vistin Pharma ASA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

OSTO:VISTINO vs ZTS, UTHR, VTRS: Short Interest Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Vistin Pharma ASA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vistin Pharma ASA Short Interest vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vistin Pharma ASA's Short Interest distribution charts can be found below:

* The bar in red indicates where Vistin Pharma ASA's Short Interest falls into.


OSTO:VISTINO
72GF Score
Vistin Pharma ASA OSTO:VISTINO
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Vistin Pharma ASA (OSTO:VISTINO) Overvalued in 2026?

Based on GuruFocus' analysis, Vistin Pharma ASA stock appears to be undervalued. The current stock price of kr20.50 is trading 20.5% below its estimated GF Value™ of kr25.77. GuruFocus considers Vistin Pharma ASA to be Modestly Undervalued.

Key valuation signals for OSTO:VISTINO:

  • Short Interest:
  • GF Value™: kr25.77 vs. price of kr20.50 (20.5% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the OSTO:VISTINO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Vistin Pharma ASA Business Description

Address Ostensjoveien 27, P.O. Box 6735 Etterstad, Oslo, NOR, 0661
Vistin Pharma ASA is a pharmaceutical company engaged in the production and supply of active pharmaceutical ingredients (APIs). The company operates in one business segment, Pharmaceuticals, and is a supplier of Metformin, which is used as a standard treatment for Type 2 diabetes. The company generates revenue across multiple geographic regions, including Africa, Europe, Asia, and North and South America.
72GF Score

Get the complete analysis for OSTO:VISTINO

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.50
Price
kr25.77
GF Value